Details of gene pathways suggest fine-tuning drugs for child brain tumors

Genomic, molecular findings by CHOP researchers will help inform personalized medicine

2013-03-26

(Press-News.org) Pediatric researchers, investigating the biology of brain tumors in children, are finding that crucial differences in how the same gene is mutated may call for different treatments. A new study offers glimpses into how scientists will be using the ongoing flood of gene-sequencing data to customize treatments based on very specific mutations in a child's tumor.

"By better understanding the basic biology of these tumors, such as how particular mutations in the same gene may respond differently to targeted drugs, we are moving closer to personalized medicine for children with cancer," said the study's first author, Angela J. Sievert, M.D., M.P.H., an oncologist in the Cancer Center at The Children's Hospital of Philadelphia.

Sievert, working with co-first author Shih-Shan Lang, M.D., in the translational laboratory of neurosurgeon Phillip Storm, M.D., and Adam Resnick, Ph.D., published a study ahead of print today in the Proceedings of the National Academy of Sciences.

The study, performed in cell cultures and animals, focused on a type of astrocytoma, the most common type of brain tumor in children. When surgeons can fully remove an astrocytoma (also called a low-grade glioma), a child can be cured. However, many astrocytomas are too widespread or in too delicate a site to be safely removed. Others may recur. So pediatric oncologists have been seeking better options---ideally, a drug that can selectively and definitively kill the tumor with low toxicity to healthy tissue.

The current study focuses on mutations in the BRAF gene, one of the most commonly mutated genes in human cancers. Because the same gene is also mutated in certain adult cancers, such as melanoma, the pediatric researchers were able to make use of recently developed drugs, BRAF inhibitors, which were already being tested with some success against melanoma in adults.

The current study provides another example of the complexity of cancer: in the same gene, different mutations behave differently. Sievert and her colleagues at Children's Hospital were among several research groups who reported almost simultaneously in 2008 and 2009 that mutations in the BRAF gene were highly prevalent in astrocytomas in children. "These were landmark discoveries, because they suggested that if we could block the action of that mutation, we could develop a new, more effective treatment for these tumors," said Sievert.

However, follow-up studies in animal models were initially disappointing. BRAF inhibitors that were effective in BRAF-driven adult melanomas made brain tumors worse—via an effect called paradoxical activation.

Further investigation revealed how tumor behavior depended on which type of BRAF mutation was involved. The first-generation drug that was effective in adult melanoma acted against point mutations in BRAF called V600E alterations. However, in most astrocytomas the mutation in the BRAF gene was different; it produced a fusion gene, designated KIAA1549-BRAF. When used against the fusion gene, the first-generation drug activated a cancer-driving biological pathway, the MAPK signaling cascade, and accelerated tumor growth.

By examining the molecular mechanisms behind drug resistance and working with the pharmaceutical industry, the current study's investigators identified a new, experimental second-generation BRAF inhibitor that disrupted the cancer-promoting signals from the fusion gene, and did not cause the paradoxical activation in the cell cultures and animal models.

This preclinical work result lays a foundation for multicenter clinical trials to test the mutation-specific targeting of tumors by this class of drugs in children with astrocytomas, said Sievert. As this effort progresses, it will benefit from CHOP's commitment to resources and collaborations that support data-intense research efforts.

The direction of brain tumor research over the past several years reflects some of those data-driven advances, says Adam C. Resnick, Ph.D., the senior author of the current paper and principal investigator of the astrocytoma research team in the Division of Neurosurgery at Children's Hospital. "For years, astrocytomas have been lumped together based on similar appearance to pathologists studying their structure, cell shape and other factors," said Resnick. "But our current discoveries show that the genetic and molecular structure of tumors provides more specific information in guiding oncologists toward customized treatments."

Earlier this year, Children's Hospital announced its collaboration with the gene-sequencing organization BGI-Shenzhen in performing next-generation sequencing of pediatric brain tumors at the Joint Genome Center, BGI@CHOP. The center's sophisticated, high-throughput sequencing technology will greatly speed the discovery of specific gene alterations involved in childhood brain cancers.

This genomic discovery program dovetails with the work of the Childhood Brain Tumor Tissue Consortium, a multi-institutional collaboration recently launched by CHOP, with support from the Children's Brain Tissue Foundation. Because even large research centers may not hold enough tumor tissue specimens to power certain research, the consortium pools samples from a group of institutions, providing an important scientific resource for cooperative studies.

"The better we understand the mutational landscape of tumors, the closer we'll be to defining therapies tailored to a patient's specific subtype of cancer," added Resnick.

###Funding from the National Institutes of Health (grants CA076931 and 5T32043126-09), the Matthew Larson Pediatric Brain Tumor Foundation, Alex's Lemonade Stand Foundation, the Rally Foundation for Childhood Cancer Research, the Bear Necessities Pediatric Cancer Foundation and A Kid's Brain Tumor Cure/PLGA Foundation supported this study. Plexxikon, Inc., provided the BRAF inhibitors used in the study. Sievert, Resnick and Storm are all on the faculty of the Perelman School of Medicine at the University of Pennsylvania in addition to their positions at Children's Hospital.

"Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomas," Proceedings of the National Academy of Sciences, Online Early Edition, March 26, 2013. http://www.pnas.org/cgi/doi/10.1073/pnas.1219232110

About The Children's Hospital of Philadelphia: The Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals and pioneering major research initiatives, Children's Hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country, ranking third in National Institutes of Health funding. In addition, its unique family-centered care and public service programs have brought the 516-bed hospital recognition as a leading advocate for children and adolescents. For more information, visit http://www.chop.edu.

ELSE PRESS RELEASES FROM THIS DATE:

Restaurant service linked to customer demographics, race, Wayne State research finds

2013-03-26

DETROIT — Restaurant servers are more likely to give better service to patron types they believe are more inclined to tip well, a Wayne State University researcher has found, a principle that has significant consequences when African-Americans are at the table. In an effort to determine whether servers based their service levels on perceived tipping differences across customer demographics, Zachary Brewster, Ph.D., assistant professor of sociology in the College of Liberal Arts and Sciences, analyzed data derived from a survey of 200 servers in 18 restaurants in a southeastern ...

Brief mindfulness training may boost test scores, working memory

2013-03-26

Mindfulness training may help to boost standardized test scores and improve working memory, according to a new study in Psychological Science, a journal of the Association for Psychological Science. Every year, millions of college and graduate-school applicants take standardized tests, such as the SAT and GRE. The tests supposedly provide a way to gauge students' cognitive abilities and predict how they'll perform in school and, eventually, the workplace. A multibillion-dollar test-prep industry has emerged out of the idea that boosting performance on these tests is ...

Astronomers discover new kind of supernova

2013-03-26

Pasadena, CA— Supernovae were always thought to occur in two main varieties. But a team of astronomers including Carnegie's Wendy Freedman, Mark Phillips and Eric Persson is reporting the discovery of a new type of supernova called Type Iax. This research has been accepted for publication in The Astrophysical Journal and is available online. Previously, supernovae were divided into either core-collapse or Type Ia categories. Core-collapse supernovae are the explosion of a star about 10 to 100 times as massive as our sun. Type Ia supernovae are the complete disruption ...

Regulation recommendations so that biofuel plants don't become weeds

2013-03-26

URBANA – In the United States, only species listed on state or federal noxious weed lists are regulated, and those lists are often biased toward species that affect agricultural crops. Conversely, invasive plant council lists include species that affect natural landscapes but have no regulatory clout. After comparing the lists and how they are created, researchers at the University of Illinois's Energy Biosciences Institute have developed some suggestions on how to improve the regulation of all invasive plant species, including new biofuels plants. "We're hoping to reform ...

Commonly used cholesterol calculation underestimates heart disease danger for many

2013-03-26

In what promises to be an eye-opener for many doctors and patients who routinely depend on cholesterol testing, a study led by researchers at the Johns Hopkins University School of Medicine found that the standard formula used for decades to calculate low-density lipoprotein (LDL) cholesterol levels is often inaccurate. Of most concern, the researchers say, is their finding that the widely used formula underestimates LDL where accuracy matters most — in the range considered desirable for high-risk patients. Results of the study are published in an online article, ahead ...

Mindfulness improves reading ability, working memory, and task-focus

2013-03-26

(Santa Barbara, Calif.) –– If you think your inability to concentrate is a hopeless condition, think again –– and breathe, and focus. According to a study by researchers at the UC Santa Barbara, as little as two weeks of mindfulness training can significantly improve one's reading comprehension, working memory capacity, and ability to focus. Their findings were recently published online in the empirical psychology journal Psychological Science. "What surprised me the most was actually the clarity of the results," said Michael Mrazek, graduate student researcher in psychology ...

Could that cold sore increase your risk of memory problems?

2013-03-26

MINNEAPOLIS – The virus that causes cold sores, along with other viral or bacterial infections, may be associated with cognitive problems, according to a new study published in the March 26, 2013, print issue of Neurology®, the medical journal of the American Academy of Neurology. The study found that people who have had higher levels of infection in their blood (measured by antibody levels), meaning they had been exposed over the years to various pathogens such as the herpes simplex type 1 virus that causes cold sores, were more likely to have cognitive problems than ...

'Metascreen' forms ultra-thin invisibility cloak

2013-03-26

Up until now, the invisibility cloaks put forward by scientists have been fairly bulky contraptions – an obvious flaw for those interested in Harry Potter-style applications. However, researchers from the US have now developed a cloak that is just micrometres thick and can hide three-dimensional objects from microwaves in their natural environment, in all directions and from all of the observers' positions. Presenting their study today, 26 March, in the Institute of Physics and German Physical Society's New Journal of Physics, the researchers, from the University of ...

Endangered lemurs' complete genomes are sequenced and analyzed for conservation efforts

2013-03-26

For the first time, the complete genomes of three separate populations of aye-ayes -- a type of lemur -- have been sequenced and analyzed in an effort to help guide conservation efforts. The results of the genome-sequence analyses will be published in an early edition of Proceedings of the National Academy of Sciences online during the week of 25 March 2013. The team of scientists is led by George H. Perry, an assistant professor of anthropology and biology at Penn State University; Webb Miller, a professor of biology and of computer science and engineering at Penn State; ...

Monoclonal antibody targets, kills leukemia cells

2013-03-26

Researchers at the University of California, San Diego Moores Cancer Center have identified a humanized monoclonal antibody that targets and directly kills chronic lymphocytic leukemia (CLL) cells. The findings, published in the online Early Edition of the Proceedings of the National Academy of Sciences on March 25, 2013 represent a potential new therapy for treating at least some patients with CLL, the most common type of blood cancer in the United States. CLL cells express high levels of a cell-surface glycoprotein receptor called CD44. Principal investigator Thomas ...

In small preliminary study, fearful pet dogs exhibited significantly different microbiomes and metabolic molecules to non-fearful dogs, suggesting the gut-brain axis might be involved in fear behavior

Examination of Large Language Model "red-teaming" defines it as a non-malicious team-effort activity to seek LLMs' limits and identifies 35 different techniques used to test them

Most microplastics in French bottled and tap water are smaller than 20 µm - fine enough to pass into blood and organs, but below the EU-recommended detection limit

Details of gene pathways suggest fine-tuning drugs for child brain tumors

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: